Ignite Creation Date:
2024-05-06 @ 9:41 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03047083
Status:
COMPLETED
Last Update Posted:
2022-01-26
First Post:
2017-02-06
Brief Title:
Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia AML With or Without FMS-like Tyrosine Kinase-3 FLT3 Mutation Study Based on Retrospective Chart Review
Sponsor:
Organization:
Astellas Pharma Inc
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
1027
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 39505 |
Who Masked List: